Novartis’ incident cause anxiety among multinational companies

As a investigation result of rebates on Novartis Korea which records the top second sales among other multinational pharmaceutical companies branched in Korea, attention has bee focused on multinational pharmaceutical companies.

Suspicion of providing illegal rebates from multinational pharmaceutical companies, which have stressed differentiation to domestic companies under the highest level ...